Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
Canet LM, Filipescu I, Cáliz R, Lupiañez CB, Canhão H, Escudero A, Segura-Catena J, Soto-Pino MJ, Ferrer MA, García A, Romani L, Pérez-Pampin E, González-Utrilla A, López Nevot MA, Collantes E, Fonseca JE, Sainz J. Canet LM, et al. Among authors: soto pino mj. Pharmacogenet Genomics. 2015 Jul;25(7):323-33. doi: 10.1097/FPC.0000000000000140. Pharmacogenet Genomics. 2015. PMID: 25850964
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control study.
Canet LM, Cáliz R, Lupiañez CB, Canhão H, Martinez M, Escudero A, Filipescu I, Segura-Catena J, Soto-Pino MJ, Ferrer MA, García A, Romani L, Pérez-Pampin E, González-Utrilla A, López Nevot MÁ, Collantes E, Fonseca JE, Sainz J. Canet LM, et al. Among authors: soto pino mj. Pharmacogenet Genomics. 2015 Sep;25(9):432-43. doi: 10.1097/FPC.0000000000000155. Pharmacogenet Genomics. 2015. PMID: 26111149
Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.
Cáliz R, Canet LM, Lupiañez CB, Canhão H, Escudero A, Filipescu I, Segura-Catena J, Soto-Pino MJ, Expósito-Ruiz M, Ferrer MÁ, García A, Romani L, González-Utrilla A, Vallejo T, Pérez-Pampin E, Hemminki K, Försti A, Collantes E, Fonseca JE, Sainz J. Cáliz R, et al. Among authors: soto pino mj. PLoS One. 2013 Aug 30;8(8):e72732. doi: 10.1371/journal.pone.0072732. eCollection 2013. PLoS One. 2013. PMID: 24023637 Free PMC article.
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, Broeder AD, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J. Canet LM, et al. Among authors: soto pino mj. Pharmacogenomics J. 2019 Feb;19(1):83-96. doi: 10.1038/s41397-018-0057-x. Epub 2018 Oct 5. Pharmacogenomics J. 2019. PMID: 30287909 Free article.
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium.
Sánchez-Maldonado JM, Cáliz R, Canet L, Horst RT, Bakker O, den Broeder AA, Martínez-Bueno M, Canhão H, Rodríguez-Ramos A, Lupiañez CB, Soto-Pino MJ, García A, Pérez-Pampin E, González-Utrilla A, Escudero A, Segura-Catena J, Netea-Maier RT, Ferrer MÁ, Collantes-Estevez E, López Nevot MÁ, Li Y, Jurado M, Fonseca JE, Netea MG, Coenen MJH, Sainz J. Sánchez-Maldonado JM, et al. Among authors: soto pino mj. Sci Rep. 2019 Oct 15;9(1):14812. doi: 10.1038/s41598-019-51255-0. Sci Rep. 2019. PMID: 31616008 Free PMC article.
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, den Broeder A, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J. Canet LM, et al. Among authors: soto pino mj. Pharmacogenomics J. 2019 Dec;19(6):582. doi: 10.1038/s41397-019-0084-2. Pharmacogenomics J. 2019. PMID: 30760878 Free article.
Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.
Notario Ferreira I, Ferrer González MA, Morales Garrido P, González Utrilla A, García Sanchez A, Soto Pino MJ, Suero Rosario E, Caro Hernández C, Añón Oñate I, Pérez Albaladejo L, Cáliz Cáliz R. Notario Ferreira I, et al. Among authors: soto pino mj. Reumatol Clin. 2017 Mar-Apr;13(2):78-84. doi: 10.1016/j.reuma.2016.03.014. Epub 2016 May 10. Reumatol Clin. 2017. PMID: 27174398 Free article. English, Spanish.
Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: a meta-analysis.
Gómez Peña C, Dávila-Fajardo CL, Martínez-González LJ, Carmona-Sáez P, Soto Pino MJ, Sánchez Ramos J, Moreno Escobar E, Blancas I, Fernández JJ, Fernández D, Correa C, Cabeza Barrera J. Gómez Peña C, et al. Among authors: soto pino mj. Pharmacogenet Genomics. 2015 Aug;25(8):388-93. doi: 10.1097/FPC.0000000000000149. Pharmacogenet Genomics. 2015. PMID: 26049584
Análisis de la producción científica en un hospital general de especialidades.
Gutiérrez Fernández J, Sorlózano Puerto A, Soto Pino MJ, de Dios Luna J. Gutiérrez Fernández J, et al. Among authors: soto pino mj. Rev Calid Asist. 2008 Jan;23(1):41-2. doi: 10.1016/S1134-282X(08)70467-6. Epub 2008 Oct 11. Rev Calid Asist. 2008. PMID: 23040045 Spanish. No abstract available.